Open Letter to Fiscal Conservatives on House Commerce Committee Concerning HF4 (Minnesota)
March 18, 2019
Letter to Minnesota lawmakers on House File No. 4, a bill that addresses generic drug pricing.
The National Taxpayers Union objects to measures to control prescription drug prices at the state level. It argues that a process to review price setting could lead to cost hikes farther down the supply chain by limiting the availability of drugs and leading to more expensive treatments, like hospitalization.